配分額 *注記 |
4,680千円 (直接経費: 3,600千円、間接経費: 1,080千円)
2026年度: 1,560千円 (直接経費: 1,200千円、間接経費: 360千円)
2025年度: 1,560千円 (直接経費: 1,200千円、間接経費: 360千円)
2024年度: 1,560千円 (直接経費: 1,200千円、間接経費: 360千円)
|
研究開始時の研究の概要 |
My current research data clearly showed LAMs formation in CD206 M2-like macrophages depleted or CD206KO mice (mice lacking CD206 antigen in M2 macrophages) mice are significantly downregulated with improved metabolism. Furthermore, I will evaluate the underlying mechanism of how CD206 deficient macrophages are challenging to develop LAMs, how CD206+ M2-like macrophages uptake free fatty acids (FFA) to become LAMs, and how miRNAs derived from LAMs-exosome suppress metabolic favorable genes to develop insulin resistance.
|